CNCR vs. PJP ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to PowerShares Dynamic Pharmaceuticals (PJP)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$13.17
Average Daily Volume
8,998
68
PJP
PowerShares Dynamic Pharmaceuticals
PJP Description
The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.Grade (RS Rating)
Last Trade
$80.08
Average Daily Volume
6,167
22
Performance
Period | CNCR | PJP |
---|---|---|
30 Days | -10.69% | -0.51% |
60 Days | -16.99% | 1.36% |
90 Days | -15.23% | 3.05% |
12 Months | 3.05% | 7.34% |
CNCR Overweight 65 Positions Relative to PJP
Symbol | Grade | Weight | |
---|---|---|---|
ELVN | C | 3.15% | |
SMMT | C | 2.57% | |
NRIX | C | 2.29% | |
ITOS | D | 2.24% | |
NUVB | D | 2.15% | |
MRUS | C | 2.09% | |
BPMC | B | 1.92% | |
RVMD | D | 1.87% | |
ACRV | F | 1.76% | |
ERAS | C | 1.72% | |
JANX | D | 1.66% | |
PGEN | C | 1.64% | |
HCM | D | 1.61% | |
CGEM | D | 1.57% | |
EXEL | C | 1.55% | |
IMTX | C | 1.52% | |
DAWN | F | 1.51% | |
AURA | F | 1.51% | |
REPL | D | 1.49% | |
FHTX | D | 1.47% | |
TSVT | F | 1.47% | |
KURA | D | 1.45% | |
NUVL | C | 1.41% | |
SNDX | D | 1.39% | |
BCYC | F | 1.37% | |
TYRA | D | 1.35% | |
XNCR | F | 1.35% | |
BNTX | F | 1.34% | |
GMAB | F | 1.31% | |
PRLD | F | 1.28% | |
RCUS | F | 1.28% | |
YMAB | D | 1.27% | |
BMY | F | 1.23% | |
ACLX | B | 1.21% | |
IPHA | D | 1.21% | |
RLAY | F | 1.2% | |
KYMR | D | 1.19% | |
IDYA | F | 1.19% | |
SWTX | D | 1.18% | |
SDGR | F | 1.17% | |
KPTI | F | 1.13% | |
STRO | F | 1.13% | |
RXRX | F | 1.09% | |
LEGN | C | 1.05% | |
IGMS | F | 1.01% | |
ACET | F | 1.01% | |
RPTX | F | 1.0% | |
LYEL | F | 0.97% | |
VOR | F | 0.96% | |
AUTL | F | 0.91% | |
ARVN | F | 0.9% | |
IMCR | F | 0.87% | |
IOVA | F | 0.87% | |
GLUE | F | 0.86% | |
ALLO | F | 0.84% | |
IMRX | F | 0.76% | |
FATE | F | 0.7% | |
MRSN | F | 0.62% | |
GNLX | F | 0.55% | |
RAPT | F | 0.53% | |
CRBU | F | 0.49% | |
ZNTL | F | 0.46% | |
DNA | F | 0.45% | |
BMEA | F | 0.42% | |
MGNX | F | 0.4% |
CNCR Underweight 19 Positions Relative to PJP
CNCR: Top Represented Industries & Keywords
PJP: Top Represented Industries & Keywords